Efficacy and safety of hydroxychloroquine for treatment of mild SARS‐CoV‐2 infection and prevention of COVID‐19 severity in pregnant and postpartum women: A randomized, double‐blind, placebo‐controlled trial

Efficacy and safety of hydroxychloroquine for treatment of mild SARS‐CoV‐2 infection and prevention of COVID‐19 severity in pregnant and postpartum women: A randomized, double‐blind, placebo‐controlled trial

Abstract Introduction Pregnant women have an increased risk of severe COVID‐19. Evaluation of drugs with a safety reproductive toxicity profile is a priority. At the beginning of the pandemic, hydroxychloroquine (HCQ) was recommended for COVID‐19 treatment. Material and methods A randomized, double‐...

Full description

Saved in:
Bibliographic Details
Main Authors: Raquel González, Anna Goncé, Mª. del Mar Gil, Edurne Mazarico, Elena Ferriols‐Pérez, Paloma Toro, Elisa Llurba, Elisa Saéz, Miguel Ángel Rodríguez‐Zambrano, Laura García‐Otero, Marta López, Belén Santacruz, Mª. Ángeles Román, Antoni Payà, Sofia Alonso, Mónica Cruz‐Lemini, Clara Pons‐Duran, Luis Bernardo Herrera, Haily Chen, Azucena Bardají, Llorenç Quintó, Clara Menendez, the COVID‐Preg research group
Format: Article
Language:English
Published: Wiley 2024-03-01
Series:Acta Obstetricia et Gynecologica Scandinavica
Subjects:
COVID‐19
hydroxychloroquine
pregnancy
randomized controlled trial
SARS‐CoV‐2
women
Online Access:https://doi.org/10.1111/aogs.14745
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1111/aogs.14745

Similar Items